본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

Radiomics in stereotactic body radiotherapy for non-small cell lung cancer: a systematic review and radiomic quality score study

이용수 7

영문명
Radiomics in stereotactic body radiotherapy for non-small cell lung cancer: a systematic review and radiomic quality score study
발행기관
대한방사선종양학회
저자명
Ben Man Fei Cheung
간행물 정보
『대한방사선종양학회지』제42권 제1호, 4~16쪽, 전체 13쪽
주제분류
의약학 > 종양학
파일형태
PDF
발행일자
2024.03.30
4,360

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

Purpose: Stereotactic body radiotherapy (SBRT) has been widely utilized for curative treatment of early-stage non-small cell lung cancer (NSCLC). It has achieved good local control rate comparable to surgery. Currently, no standard risk model exists for SBRT outcome or complication prediction. Radiomics has the potential to improve clinical outcome prognostication. Here, we reviewed the current literature on the radiomic analyses of thoracic SBRT through the use of radiomic quality score (RQS). Materials and Methods: Literature search was conducted on PubMed and Embase to retrieve radiomics studies on SBRT for early NSCLC. The literature search included studies up to June 2021. Only full papers published in peer reviewed journals were included. Studies that included metastatic lung cancers or non-lung cancers were excluded. Two independent investigators evaluated each study using the RQS and resolved discrepancies through discussion. Results: A total number of 25 studies were analysed. The mean RQS was 7.76 of a maximum score of 36. This corresponds to 21.56% of the maximum score. Lack of feature reduction strategies, external validation and open data sharing were identified as key limitations of the reviewed studies. Meanwhile, various common radiomic signatures across different studies such as gray level co-occurrence matrix Homogeneity and energy have been identified. Multiple robust radiomic models have also been reviewed that may improve outcome or complication prediction. Conclusion: Radiomics in thoracic SBRT has a very promising future as a prognostication tool. However, larger multicenter prospective studies are required to confirm radiomic signatures. Improvement in future study methodologies can also facilitate its wider application.

목차

Introduction
Materials and Methods
Results
Discussion and Conclusion
Statement of Ethics
Conflict of Interest
Funding
Author Contributions
Data Availability Statement
Supplementary Materials
References

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

Ben Man Fei Cheung. (2024).Radiomics in stereotactic body radiotherapy for non-small cell lung cancer: a systematic review and radiomic quality score study. 대한방사선종양학회지, 42 (1), 4-16

MLA

Ben Man Fei Cheung. "Radiomics in stereotactic body radiotherapy for non-small cell lung cancer: a systematic review and radiomic quality score study." 대한방사선종양학회지, 42.1(2024): 4-16

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제